US EditionPublished • loading... • Updated
The Risk of Trivializing the Treatment of Obesity
Summary by EfeSalud
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
In the last decade there has been a revolution of the new drugs to treat obesity, in fact, in 2021, the FDA of the United States approved one of these compounds with a specific dose for chronic weight management, which increased their use, both for medical prescriptions and for media attention and social networks. Thus, drugs such as semaglutide, liraglutide or tirzepatide enter into the digital debate (under their commercial names) on diets and…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
